Carafate and Weight decreased for Women aged 20-29 (a phase IV clinical study of FDA data)
Summary:
Weight decreased is found for women aged 20-29 who take Carafate (sucralfate). This study is created by eHealthMe based on reports of 233 women aged 20-29 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:
- Time on Carafate when people have Weight decreased
- Top conditions
- Top co-used drugs
- Top other side effects
233 women aged 20-29 reported to have side effects when taking Carafate.
Among them, 18 people (7.73%) have Weight decreased
What is Carafate?
Carafate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 14,028 Carafate users. Check the latest studies of Carafate.
What is Weight decreased?
Weight decreased is found to be associated with 3,435 drugs and 4,715 conditions by eHealthMe. Check the latest studies of Weight decreased.
Number of reports submitted per year:

Time on Carafate when people have Weight decreased *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Severity of Weight decreased
n/aHow people recovered from Weight decreased
n/aTop conditions involved for these people *:
You may use this to check any potential undetected conditions.
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 16.67%
- Asthma: 3 people, 16.67%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 16.67%
- Stress And Anxiety: 2 people, 11.11%
- Multiple Allergies (allergy to multiple agents): 2 people, 11.11%
- Mood Swings (an extreme or rapid change in mood): 2 people, 11.11%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 11.11%
- Joint Pain: 2 people, 11.11%
- Birth Control: 2 people, 11.11%
- Tuberous Sclerosis (a rare genetic disease that causes benign tumours to grow in the brain and other organs): 1 person, 5.56%
Top co-used drugs for these people *:
You may use this to check any potential interacting drugs.
- Nexium: 8 people, 44.44%
- Zyrtec: 5 people, 27.78%
- Flagyl: 5 people, 27.78%
- Yaz: 5 people, 27.78%
- Propulsid: 4 people, 22.22%
- Phenergan: 3 people, 16.67%
- Singulair: 3 people, 16.67%
- Claritin: 3 people, 16.67%
- Probiotic: 3 people, 16.67%
- Prilosec: 3 people, 16.67%
Top other side effects for these people *:
You may use this to check any potential undetected side effects.
- Nausea (feeling of having an urge to vomit): 9 people, 50.00%
- Abdominal Pain Upper: 6 people, 33.33%
- Cholecystitis Chronic (long lasting infection of gallbladder): 5 people, 27.78%
- Diarrhea: 5 people, 27.78%
- Nausea And Vomiting: 5 people, 27.78%
- Hypokalemia (low potassium): 5 people, 27.78%
- Depression: 4 people, 22.22%
- Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 3 people, 16.67%
- Hyperventilation: 3 people, 16.67%
- Drowsiness: 3 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Carafate and have Weight decreased?
- Check whether Weight decreased is associated with a drug or a condition- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies:
How the study uses the data?
The study is based on (applicable) gender, age, sucralfate (the active ingredients of Carafate) and Carafate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Sodium Chloride and Tacrolimus - now
- Could Zyvox cause Facial Pain? - 4 seconds ago
- Could Vyvanse cause Psoriasis Aggravated? - 10 seconds ago
- Mirabegron and Pain In Extremity for Women aged 60+ - 10 seconds ago
- Could Sunosi cause Visual Impairment? - 11 seconds ago
- Could Vasotec cause Angioneurotic Oedema? - 21 seconds ago
- Drug interactions of Bactrim and Calquence - 25 seconds ago
- Could Metformin cause Pseudoporphyria? - 27 seconds ago
- How effective is Zyprexa for Generalized Anxiety Disorder? - 28 seconds ago
- Drug interactions of Oxybutynin Chloride and Paroxetine Hydrochloride - 33 seconds ago